Amesite (NASDAQ:AMST) stock is rocketing higher on Wednesday after the artificial intelligence (AI) company announced the launch of a beta version of its NurseMagic app.
NurseMagic is a tool designed by Amesite that assists nurses with their daily tasks. The company says it could help up to 5.2 million nurses be more efficient by helping them with its AI tools.
Amesite also notes that it’s a Joint Provider with PACE. This means it can offer accredited continuing education to nurses through the app. This can assist them with obtaining their nursing licenses.
Dr. Ann Marie Sastry, CEO of Amesite, said the following about the NurseMagic beta launch:
“Launching apps enables us to directly reach much larger audiences. We want to equip every nurse on the planet with tools that deliver immediate, qualified information, and address the demands on their time while leveraging their expertise. We intend to partner in this sector as we provide professional learning right on the app, and plan to have more announcements as we roll out additional features.”
AMST Stock Movement Today
With the news of this app launch comes heavy trading of AMST stock. This has more than 52 million shares changing hands as of this writing. That’s a massive increase compared to its daily average trading volume of about 28,000 shares.
AMST stock is up 73.9% as of Wednesday morning.
Investors will find more of the most recent stock market stories ready to go down below!
We have all of the hottest stock market news worth reading about on Wednesday! Among that is why shares of Tesla (NASDAQ:TSLA), Stellantis (NASDAQ:STLA) and Fabrinet (NYSE:FN) stock are in the news today. All of that info is available at the following links!
More Wednesday Stock Market News
- TSLA Stock Alert: Tesla Axes Plans for $25,000 Model 2
- Stellantis Layoffs 2024: What to Know About the Latest Jeep Job Cuts
- Why Is Fabrinet (FN) Stock Down Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
